Search Results - "Schirosi, Laura"

Intratumoral, rather than stromal, CD8+ T cells could be a potential negative prognostic marker in invasive breast cancer patients by Catacchio, Ivana, Silvestris, Nicola, Scarpi, Emanuela, Schirosi, Laura, Scattone, Anna, Mangia, Anita

“…BACKGROUND: Tumor infiltrating lymphocytes (TILs) are widely considered a key sign of the immune interaction between host and tumor, and potentially prognostic…”
Get full text

Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients? by Schirosi, Laura, Strippoli, Sabino, Gaudio, Francesca, Graziano, Giusi, Popescu, Ondina, Guida, Michele, Simone, Giovanni, Mangia, Anita

“…In clinical practice the gold standard method to assess BRAF status in patients with metastatic melanoma is based on molecular assays. Recently, a…”
Get full text

De-Implementation of Axillary Staging and Radiotherapy in Low-Risk Breast Cancer Patients Aged 70-79 Years from Six Italian Cancer Institutes by Bucchi, Lauro, Ravaioli, Alessandra, Dal Maso, Luigino, Falcini, Fabio, Mangone, Lucia, Massarut, Samuele, Schirosi, Laura, Crispo, Anna, Vici, Patrizia, Franceschi, Silvia

“…In women aged ≥70 with low-risk breast cancer (BrC), some major international guidelines recommend against sentinel lymph node biopsy (for example, those from…”
Get full text

Downstream Signaling of Inflammasome Pathway Affects Patients' Outcome in the Context of Distinct Molecular Breast Cancer Subtypes by Saponaro, Concetta, Fanizzi, Annarita, Sonnessa, Margherita, Mondelli, Paolo, Vergara, Daniele, Loisi, Donato, Massafra, Raffaella, Latorre, Agnese, Zito, Francesco A, Schirosi, Laura

“…Inflammasomes are protein complexes involved in the regulation of different biological conditions. Over the past few years, the role of NLRP3 in different…”
Get full text

Discordance between FISH, IHC, and NGS Analysis of ALK Status in Advanced Non–Small Cell Lung Cancer (NSCLC): a Brief Report of 7 Cases by Scattone, Anna, Catino, Annamaria, Schirosi, Laura, Caldarola, Lucia, Tommasi, Stefania, Lacalamita, Rosanna, Montagna, Elisabetta Sara, Galetta, Domenico, Serio, Gabriella, Zito, Francesco Alfredo, Mangia, Anita

“…BACKGROUND: Anaplastic lymphoma kinase (ALK) rearrangement represents a landmark in the targeted therapy of non–small cell lung cancer (NSCLC)…”
Get full text

Role of Chemotherapy and the Receptor Tyrosine Kinases KIT, PDGFRα, PDGFRβ, and Met in Large-Cell Neuroendocrine Carcinoma of the Lung by ROSSI, Giulio, CAVAZZA, Alberta, FACCIOLONGO, Nicola, MAIORANA, Antonio, BAVIERI, Mario, FABBRI, Leonardo M, BRAMBILLA, Elisabeth, MARCHIONI, Alessandro, LONGO, Lucia, MIGALDI, Mario, SARTORI, Giuliana, BIGIANI, Nazzarena, SCHIROSI, Laura, CASALI, Christian, MORANDI, Uliano

“…Purpose Pulmonary large-cell neuroendocrine carcinoma (LCNEC) is a relatively uncommon, high-grade neuroendocrine tumor sharing several features with…”
Get full text

Tumor Infiltrating Lymphocytes and NHERF1 Impact on Prognosis of Breast Cancer Patients by Schirosi, Laura, Saponaro, Concetta, Giotta, Francesco, Popescu, Ondina, Pastena, Maria Irene, Scarpi, Emanuela, Mangia, Anita

“…BACKGROUND: Breast cancer (BC) is a heterogeneous disease, and patients with apparently similar clinicopathological characteristics in clinical practice show…”
Get full text

VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab-Based Treatment by Schirizzi, Annalisa, Arshadi, Aram, Tolomeo, Doron, Schirosi, Laura, Valentini, Anna Maria, De Leonardis, Giampiero, Refolo, Maria Grazia, Donghia, Rossella, Storlazzi, Clelia Tiziana, Zito, Alfredo, Ricci, Angela Dalia, Vallarelli, Simona, Ostuni, Carmela, Bencivenga, Maria, De Manzoni, Giovanni, Messa, Caterina, Armentano, Raffaele, Giannelli, Gianluigi, Lotesoriere, Claudio, D'Alessandro, Rosalba

“…Metastatic gastric cancer (mGC) often has a poor prognosis and may benefit from a few targeted therapies. Ramucirumab-based anti-angiogenic therapy targeting…”
Get full text

The role of fetal autopsy and placental examination in the causes of fetal death: a retrospective study of 132 cases of stillbirths by Bonetti, L. Reggiani, Ferrari, P., Trani, N., Maccio, L., Laura, Schirosi, Giuliana, Sartori, Facchinetti, F., Rivasi, F.

“…Purpose To investigate the most plausible cause of stillbirth by evaluating clinical records and postmortem examination findings including placental analysis…”
Get full text

Thyroglobulin Determination in Fine Needle Aspiration Biopsy Washout of Suspicious Lymph Nodes in Thyroid Carcinoma Follow up by Achille, Gaetano, Garrisi, Vito M, Russo, Sabino, Guastamacchia, Edoardo, Giagulli, Vito A, Schirosi, Laura, Daniele, Antonella, Tufaro, Antonio, Cafagna, Vito, Centrone, Marilena, Simone, Giovanni, Abbate, Ines, Triggiani, Vincenzo

“…Differentiated thyroid carcinomas (DTCs) account for about 1% of all human malignancies. Cervical lymph nodes metastases and recurrences in the thyroid bed…”
Get more information

Imatinib inhibits in vitro proliferation of cells derived from a pleural solitary fibrous tumor expressing platelet-derived growth factor receptor-beta by Prunotto, Marco, Bosco, Martino, Daniele, Lorenzo, Macri’, Luigia, Bonello, Lisa, Schirosi, Laura, Rossi, Giulio, Filosso, Pierluigi, Mussa, Baudolino, Sapino, Anna

“…Abstract We examined the in vitro effects of imatinib (Novartis Pharma AG, Basel, Switzerland) as a possible inhibitor of PDGFR pathway on cells derived from a…”
Get full text

VEGF and TWIST1 in a 16‐biomarker immunoprofile useful for prognosis of breast cancer patients by Schirosi, Laura, De Summa, Simona, Tommasi, Stefania, Paradiso, Angelo, Gasparini, Giampietro, Popescu, Ondina, Simone, Giovanni, Mangia, Anita

“…This study concerns the expression of biomarkers involved in diverse pathways, such as progression, DNA repair mechanisms and angiogenesis to establish an…”
Get full text

NHERF1 together with PARP1 and BRCA1 expression as a new potential biomarker to stratify breast cancer patients by Mangia, Anita, Scarpi, Emanuela, Partipilo, Giulia, Schirosi, Laura, Opinto, Giuseppina, Giotta, Francesco, Simone, Giovanni

“…It has been recognized that Na /H Exchanger Regulatory Factor 1 (NHERF1) in breast cancer (BC) acts as a tumor suppressor or as an oncogenic protein, depending…”
Get full text

Impressive response with imatinib in a heavily pretreated patient with metastatic c-KIT mutated thymic carcinoma by Buti, Sebastiano, Donini, Maddalena, Sergio, Pietro, Garagnani, Lorella, Schirosi, Laura, Passalacqua, Rodolfo, Rossi, Giulio

Get full text

The role of rapid on site evaluation on touch imprint cytology and brushing during conventional bronchoscopy by Botticella, Maria Antonietta, De Summa, Simona, Cisternino, Luigi, Tommasi, Stefania, Pastena, Maria Irene, Schirosi, Laura, Mangia, Anita, Mele, Fabio, Lozupone, Antonietta, Scattone, Anna, Siciliano, Michele, Sozio, Rosa, Zito, Francesco Alfredo

“…Background The increase in immunohistochemical and molecular predictive tests in lung cancer requires new strategies for managing small samples taken during…”
Get full text

Pleuro-pulmonary Solitary Fibrous Tumors : A Clinicopathologic, Immunohistochemical, and Molecular Study of 88 Cases Confirming the Prognostic Value of de Perrot Staging System and p53 Expression, and Evaluating the Role of c-kit, BRAF, PDGFRs (α/β), c-met, and EGFR by SCHIROSI, Laura, LANTUEJOUL, Sylvie, CAVAZZA, Alberto, MURER, Bruno, YVES BRICHON, Pierre, MIGALDI, Mario, SARTORI, Giuliana, SGAMBATO, Alessandro, ROSSI, Giulio

“…Pleuro-pulmonary solitary fibrous tumor (SFT) is a relatively uncommon mesenchymal neoplasm of uncertain histogenesis, unknown molecular features, and…”
Get full text

Fine Needle Aspiration Cytology: A Tool to Study NHERF1 Expression as a Potential Marker of Aggressiveness in Lung Cancer by Mangia, Anita, Partipilo, Giulia, Schirosi, Laura, Saponaro, Concetta, Galetta, Domenico, Catino, Annamaria, Scattone, Anna, Simone, Giovanni

“…Non-small cell lung cancer (NSCLC) is the leading cause of cancer death worldwide and cytology is often the only diagnostic approach. Na + /H + exchanger…”
Get full text

β-catenin interaction with NHERF1 and RASSF1A methylation in metastatic colorectal cancer patients by Schirosi, Laura, Mazzotta, Annalisa, Opinto, Giuseppina, Pinto, Rosamaria, Graziano, Giusi, Tommasi, Stefania, Fucci, Livia, Simone, Giovanni, Mangia, Anita

“…There is an increasing need to identify new biomarkers in colorectal cancer (CRC) to further characterize this malignancy. β-catenin plays a central role in…”
Get full text

Immunoprofile from tissue microarrays to stratify familial breast cancer patients by Schirosi, Laura, De Summa, Simona, Tommasi, Stefania, Paradiso, Angelo, Sambiasi, Domenico, Popescu, Ondina, Simone, Giovanni, Mangia, Anita

“…Familial breast cancer (BC) is a heterogeneous disease with variable prognosis. The identification of an immunoprofile is important to predict tumor behavior…”
Get full text

Intratumoral, rather than stromal, CD8+ T cells could be a potential negative prognostic marker in invasive breast cancer patients12 by Catacchio, Ivana, Silvestris, Nicola, Scarpi, Emanuela, Schirosi, Laura, Scattone, Anna, Mangia, Anita

“…BACKGROUND: Tumor infiltrating lymphocytes (TILs) are widely considered a key sign of the immune interaction between host and tumor, and potentially prognostic…”
Get full text